Company is pleased to announce that USFDA has concluded that their inspection is "closed" under 21 CFR 20.64(d)(3). With the above audit closure confirmation received from the USFDA, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Veerhealth Care Ltd announced on 16th May 2025 that the USFDA has formally concluded its inspection as 'closed' under 21 CFR 20.64(d)(3). With this regulatory clearance, the company is now fully qualified to export its oral care products to the USA market. The company's manufacturing facility is located in Vapi, Gujarat. This marks a key compliance milestone that removes a regulatory hurdle for entering the US market.
Positive for shareholders — USFDA clearance opens the door to the large US oral care market, which could support future revenue growth and export earnings, though no specific order or revenue guidance has been announced yet.